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Abstract
We have raised monoclonal antibodies (mAbs) directed towards
amastigote forms of Trypanosoma cruzi, and shown that mAbs 1D9
and 4B9 are carbohydrate while mAb 4B5 activity is resistant to
periodate oxidation of the antigen. Here we used an ELISA to quanti-
tate and compare the expression of surface epitopes on fixed parasites
among different parasite isolates. The expression of markers varied
among T. cruzi amastigotes isolated from infected cells or after
extracellular differentiation of trypomastigotes. Moreover, we also
observed an extensive polymorphic expression of these epitopes
among amastigotes derived from different strains and clones. For
instance, mAb 2C2 strongly and evenly reacted with 9 strains and
clones (G, Y, CL, Tulahuen, MD, and F, and clones Sylvio X-10/4,
D11, and CL.B), with absorbance at 492 nm (A492 nm) from 0.6 to 0.8.
By contrast, mAb 4B5 had a higher expression in Tulahuen amasti-
gotes (around 0.9 at 492 nm) whereas its reactivity with amastigotes
from clones CL.B, Sylvio X-10/4 and D11 was much lower (around
0.4). mAb 1D9 displayed an interesting pattern of reactivity with
amastigotes of the different strains and clones (A492 nm of
G>D11 ‡ Sylvio X-10/4 = MD>Tulahuen = F = Y>CL>CL.B). Fi-
nally, we observed that mAb 4B9 had the lowest reaction with the
parasites studied, with higher values of A492 nm with Y strain (around
0.6) and lower values with Tulahuen, F and CL.B strains (around 0.2).
Immunoblotting analysis also showed extensive variations among
amastigotes of the various parasite isolates and mAbs 4B9, 1D9 and
4B5 revealed significant differences in expression between clones and
parental strains. These data describe a previously uncharacterized
polymorphism of T. cruzi amastigote surface components.
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Introduction
Trypanosoma cruzi, the causative agent
of Chagas disease, exists in nature as a
complex and highly variable population (1).
Thus, a variety of strains and clones isolated
and used by different laboratories display
very distinct biological properties (1-3). Prop-
erties such as tissue tropism (4), resistance to
complement lysis (5), virulence (6), and in-
fectivity in different animal models (7) were
extensively examined using either metacy-
clic or tissue culture-derived trypomastigotes,
regarded as the classic infective form of the
parasite. Several studies attempting to corre-
late strain and clone polymorphism with bio-
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logical properties of trypomastigotes have
implicated specific surface antigens (8-12).
Tissue culture-derived trypomastigotes may
differentiate extracellularly into amastigotes
that resemble the proliferative intracellular
forms in many aspects (13). T. cruzi amasti-
gotes have also been shown to be infective,
both for phagocytic (14-16) and non-phago-
cytic cells (14,17,18). Although it has been
reported that amastigotes express specific
membrane components that might be in-
volved in their uptake by phagocytes (16,19),
the parasite molecules involved in cell inva-
sion, particularly of non-professional phago-
cytes, are still unknown. Detailed work by
Andrews et al. (13,20) showed that both
intracellular and extracellular forms express
a major surface glycoprotein designated Ssp-
4 that is bound to the membrane via a GPI
anchor. Another T. cruzi amastigote-specif-
ic component named amastin was recently
isolated by Teixeira et al. (21). Although its
relation to Ssp-4 is unclear at the moment,
the analysis of the amastin sequence indi-
cates that it is a hydrophobic polypeptide
lacking the characteristic GPI-anchor se-
quence (22) that would be expected for Ssp-
4. Other amastigote specific antigens that
have recently been cloned and sequenced
based on previously published amino-termi-
nal sequence data (23) were shown to belong
to the trans-sialidase/sialidase superfamily
(24). In the present study we show that T.
cruzi amastigotes from distinct strains and
clones express different epitopes in a poly-
morphic manner, similar to that described
for epitopes defined for other parasite stages.
Material and Methods
Parasites and cells
Extracellular amastigotes (EA) from T.
cruzi G (25), Y (26), CL (27), CL.B clone
(28), MD (provided by Maria P. Deane from
Instituto Oswaldo Cruz, Rio de Janeiro, RJ,
Brasil), F (29), Sylvio X-10/4 clone (30) and
Tulahuen (31) strains were isolated after
differentiation of tissue culture-derived try-
pomastigotes in LIT medium as previously
described (13) and intracellular (IA) para-
sites were purified from infected Vero cells
after mechanical disruption and centrifuga-
tion through a 10/15% metrizamide gradient
(32). We also examined, for comparison,
amastigotes isolated from supernatants of
infected Vero cells, which were designated
tissue culture amastigotes (TCA). In several
experiments we used a clone, designated
D11, isolated in our laboratory from G strain
by the method described by Lima and Vil-
lalta (33), and the clone CL.B. Some charac-
teristics of the D11 clone resemble the pa-
rental strain. D11 causes subpatent parasite-
mias in outbred albino mice, and metacyclic
trypomastigotes displaying the monoclonal
antibody (mAb) 1G7-reactive antigen, gp90,
are completely lysed by this mAb (10,34).
Vero cells (obtained from Instituto Adolfo
Lutz, Sªo Paulo, SP, Brasil) were cultured in
RPMI-1640 medium supplemented with 10%
fetal bovine serum (FBS, Cultilab, Campi-
nas, SP, Brasil), 10 µg/ml streptomycin, 100
U/ml penicillin, and 40 µg/ml gentamycin at
37oC in a 5% CO2 humid atmosphere. Cells
were subcultured every 2/3 days and after
infection they were kept in RPMI/2% FBS at
33oC to improve the yield of released trypo-
mastigotes.
Monoclonal antibodies
mAbs were produced by immunizing
BALB/c mice with amastigotes from clone
D11 of the G strain. Their isolation and
immunochemical characterization have been
described elsewhere (35). Briefly, mAb 4B5
(IgG1) was obtained from mice immunized
with psoralen/UV-inactivated (36) intracel-
lular amastigotes, and mAbs 1D9 (IgG3)
and 4B9 (IgG3) were isolated after immuni-
zation with mixtures of heat-inactivated in-
tracellular and extracellular amastigotes of
the same clone D11.
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All antibodies were used as ascitic fluids
previously titrated onto fixed parasites (see
below) before routine use to determine the
highest dilution that provided maximum ab-
sorbance at 492 nm (1:200 for anti-p30,
1D9, 4B5, and 4B9; 1:1000 for 2C2). mAb
2C2 (IgG2a), which is specific for the stage-
specific 84-kDa glycoprotein of T. cruzi
amastigotes (13), was kindly provided by
Norma Andrews (Yale University School of
Medicine, New Haven, CT, USA), and mAb
anti-p30 (IgG2b), specific for a 30-kDa pro-
tein of L. (L.) amazonensis amastigotes (37),
was kindly provided by Clara L. BarbiØri
(Universidade Federal de Sªo Paulo, Sªo
Paulo, SP, Brasil).
ELISA on glutaraldehyde-fixed amastigotes
Isolated parasites were washed 3 times in
phosphate-buffered saline (PBS) and 50 µl
containing 1 x 106 parasites was added to the
wells of ELISA strip plates (Costar, medium
or high binding capacity) and centrifuged at
800 g for 5 min. The supernatant was care-
fully removed by aspiration and the para-
sites were fixed with 0.25% (v/v) glutaralde-
hyde (Electron Microscopy Sciences, Fort
Washington, PA, USA) in PBS at room tem-
perature for 20 min. After 4 washes in PBS
to remove excess glutaraldehyde, the wells
were blocked for at least 12 h at 4oC with 5%
defatted powdered milk in PBS/0.05% so-
dium azide (PBS-M). At this stage, plates
could be stored at -20oC for at least three
months. Prior to use, the plates were warmed
to room temperature for all subsequent steps:
the PBS/milk was removed and the parasites
were incubated with 50 µl of the antibodies
diluted 1:50 in PBS-M for 1 h. After 3
washes with PBS, the bound Ig was devel-
oped by incubation with anti-mouse Ig
coupled to horseradish peroxidase (Sigma
Chemical Co., St. Louis, MO, USA) diluted
1:2000 (titrated dilution) in PBS-M. After 1
h the conjugate was washed 3 times with
PBS and 50 µl of substrate solution (10 mg
o-phenylenediamine (OPD) diluted in 25 ml
0.16 M citrate-phosphate buffer, pH 5.0,
plus 10 µl of 30% H2O2) was added to each
well as the substrate for the reaction. The
enzymatic reaction was stopped after 4 min
with 4 N H2SO4, and absorbance at 492 nm
was determined with a Multiskan MS 352
reader (Labsystems, Helsinki, Finland). All
readings were made in quintuplicate for each
determination, in at least three independent
experiments.
ELISA standardization
In order to assess the reliability, sensitiv-
ity and reproducibility of the ELISA in evalu-
ating differences in the levels of expression
of amastigote surface antigens, we performed
several controls. First, we determined that a
variation of up to 15% in the number of
parasites/well did not significantly (less than
10% in absorbance values) influence the
final values (Figure 1). This ensured that
possible errors in parasite counting did not
affect the final absorbance values. Second,
we repeated the experiments with the differ-
ent antibodies several times, using stored or
freshly prepared fixed-amastigote plates, and
Figure 1 - ELISA absorbance is
not substantially altered with dif-
ferences up to 15% in the num-
ber of parasites. Extracellular
amastigotes from clone D11
were obtained in LIT medium af-
ter 48 h of incubation, counted
and dispensed in increasing
quantities in strip wells for ELISA
with mAbs 1D9, 2C2, 4B5, 4B9
and anti-p30 (the last one used
as a negative control). Each point
indicates the mean plus one
standard deviation for a triplicate
determination.A
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always obtained consistent results where the
relative values of absorbance of the different
mAbs were the same in experiments carried
out up to two months apart (data not shown).
Third, the antibodies always retained their
specificity and heterologous reagents always
gave background values when applied to
fixed amastigotes (data not shown). Fourth,
using ELISA, we confirmed the results of
Andrews et al. (20), who reported that the
surface expression of Ssp-4 antigen on ex-
tracellular amastigotes is high after 24 h of
differentiation and decreases if parasite cul-
ture in LIT medium proceeds for up to 72 h.
However, the signal of an irrelevant mAb
was not altered during this period (data not
shown). The reduction in the expression of
surface Ssp-4 is accounted for by phospholi-
pase cleavage of the GPI anchor of the mol-
ecule, releasing soluble Ssp-4 into the cul-
ture medium (20).
Protein gel electrophoresis and
immunoblotting
Sodium dodecyl sulfate electrophoresis
(38) and immunoblotting (39) of protein
amastigote extracts were performed on 10%
resolving gels using a mini-PROTEAN Ò  II
electrophoresis cell and a mini-trans-blot
module (Bio-Rad Laboratories, Hercules,
CA, USA), as previously described (10,35).
Results
Surface expression of amastigote epitopes is
variable among different T. cruzi strains and
clones
We established that our ELISA could
reliably identify differences in the surface
expression of epitopes defined by our mAbs.
The nature of the epitopes recognized by
mAbs 1D9, 4B5 and 4B9 was determined
previously (35). Briefly, 10 mM sodium m-
periodate treatment of blots containing pro-
tein amastigote (G strain) extracts abolished
immunoblot reactivity of mAbs 1D9 and
4B9 but not 4B5, suggesting that only the
last mAb may recognize a protein moiety,
while the other two recognize carbohydrate
epitopes. The observations that L-fucose in-
hibits the binding of 2C2 to glutaraldehyde-
fixed amastigotes in ELISA indicate that the
corresponding epitope may also be a carbo-
hydrate in nature (Verbisck NV, Da-Silva S
and Mortara RA, unpublished data).
We next determined the relative expres-
sion of the epitopes recognized by mAbs
1D9, 2C2 and 4B5 in IA and EA isolated
from either culture supernatants (TCA) or
LIT medium (Extra). Figure 2 shows that,
unlike mAb 2C2 that is expressed abun-
dantly in all forms, the epitopes recognized
by mAbs 1D9, 4B9 and 4B5 were consider-
ably more abundant in intracellular parasite
form.
We subsequently examined the reactivi-
ties of the mAbs in ELISA, using extracellu-
lar amastigotes of different strains. The re-
sults are summarized in Figure 3 and indi-
cate that the mAbs can detect substantial
inter-strain variation in their relative expres-
sions. Several interesting features emerge
from the analysis of these results: i) the
epitope identified by 1D9 (Figure 3A) was
scarce in the Y and CL strains, and present in
intermediate amounts in MD, Tulahuen, and
F amastigotes; ii) the epitope recognized by
mAb 2C2 was more evenly represented in all
A
bs
or
ba
nc
e 
at
 4
92
 n
m
0.5
0
Intra Extra TCA
Amastigote source
Figure 2 - Expression of epitopes
defined by mAbs 1D9, 2C2, 4B5
and 4B9 is variable among amas-
tigotes obtained from different
sources. Amastigotes from
clone D11 were isolated from
infected cells (Intra), LIT medi-
um after 48 h (Extra) or infected
Vero cell supernatants (TCA),
and studied by ELISA. Bars indi-
cate mean value plus one stan-
dard deviation for a quintuplicate
determination. mAb anti-p30
was used as a negative control.
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strains (Figure 3B); iii) the mAb 4B5 target
was more abundant in Tulahuen, G, and CL
parasites and was moderately expressed in Y
and MD isolates (Figure 3C); iv) the mAb
4B9 epitope was poorly expressed in
Tulahuen and CL parasites but was more
abundant in MD, G and Y parasites (Figure
3D). We also observed with some mAbs
marked differences in epitope expression
between clones and parental strains. For in-
stance, whereas 2C2 expression by CL.B
was higher than CL expression, the opposite
pattern was observed with the other epitopes
which were more abundant in the parental
strain (Figure 3). Similarly, epitopes recog-
nized by mAbs 4B9 and 2C2 were equally
abundant in clone D11 and in the G strain but
mAbs 1D9 and 4B5 had a higher expression
in the parental strain (Figure 3).
Expression of amastigote antigens was
polymorphic among T. cruzi isolates
Immunoblotting analysis using mAbs
1D9, 2C2, 4B5, and 4B9 revealed a poly-
morphic pattern of antigen expression a-
mong the different strains and clones. As
shown in Figure 4, several bands present in
some isolates were clearly not detected in
others (e.g., 1D9 in CL, Y strains), while the
relative molecular masses may also vary to a
substantial extent (e.g., 4B5 in G, Sylvio X-
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Figure 3 - Expression of epitopes
defined by mAbs 1D9, 2C2, 4B5
and 4B9 is variable among amas-
tigotes of different T. cruzi
strains and clones. Extracellular
amastigotes were obtained in
LIT medium after a 48-h incuba-
tion and analyzed by ELISA. Bars
indicate the mean subtracted
from the background values ob-
tained with mAb anti-p30 (al-
ways lower than 0.2) plus one
standard deviation for a quintu-
plicate determination.
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10/4, and F strains). However, the absence
of immunoblot reaction in some strains that
give positive reaction by ELISA (e.g., 1D9
reaction with Y, CL and CL.B) can be ex-
plained by the behavior of this mAb under
different experimental conditions, since this
antibody is still capable of immunoprecipi-
tating an 84-kDa component or to surface
label Y and CL (but not CL.B) extracellular
amastigotes by immunofluorescence (35).
In a similar way, mAb 2C2 immunoprecipi-
tated an 84-kDa major component of G,
D11, Sylvio X-10/4 and CL.B extracellular
amastigotes despite its poor or absent reac-
tion with these parasites in immunoblot (data
not shown; Figure 4). Conversely, immuno-
blot reaction of mAb 4B5 was not observed
in ELISA, e.g., the poor reaction with D11,
CL.B and Sylvio X-10/4. This apparent
lack of correlation could be explained if we
assume that there is a significant reaction
of this mAb with D11 cytoplasmic compo-
nents of amastigotes as shown by immuno-
fluorescence and immunoelectronmicros-
copy (35).
Discussion
Amastigotes obtained by axenic differ-
entiation of tissue culture trypomastigotes
contain a major 84-kDa iodinatable glyco-
protein designated Ssp-4 that is linked to the
parasite membrane through a GPI anchor
(13,20). Ssp-4 and other structurally related
components are the parasites immunodom-
inant elements since they are readily recog-
nized by different mAbs raised against iso-
lated amastigotes (13,23,35,40). In the pres-
ent study we have described a previously
uncharacterized polymorphism of T. cruzi
amastigote surface components. Using mAbs
directed at carbohydrate and non-carbohy-
Figure 4 - Reactivity of mAbs 1D9, 2C2, 4B5 and 4B9 with amastigote polypeptides is polymorphic among different T. cruzi
strains and clones. Extracellular amastigote (LIT medium) extracts were processed for immunoblotting as described else-
where (35). Apparent molecular masses in kilodaltons are indicated on the left of each panel.
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drate epitopes located on the parasite sur-
face, we could detect by ELISA both strain
and clonal variation in the expression of
these epitopes among amastigotes of differ-
ent T. cruzi isolates. In addition, immuno-
blotting analysis of these parasites using the
same mAbs revealed particular patterns of
reaction, indicating a polymorphism in the
expression of these antigens among the dif-
ferent strains and clones of T. cruzi. A simi-
lar behavior regarding distinct reactivities of
mAbs in different immunochemical assays
(e.g., immunofluorescence, immunoblotting,
complement-mediated lysis and agglutina-
tion) has been extensively documented in
the literature. We have previously described
a similar trend in the expression of a mucin
and of a major surface component of T. cruzi
metacyclic trypomastigotes (10,11).
We have observed that most of the mAbs
that recognize Ssp-4 react with carbohy-
drate epitopes (35), a fact that has facilitated
the use of glutaraldehyde fixation in our
ELISAs. Indeed, a survey of the literature
shows that most of the mAbs raised against
T. cruzi amastigotes recognize carbohydrate
epitopes (13,23). These observations sug-
gest that these developmental stages are cov-
ered with a significant proportion of sugar
residues. Polymorphism of surface molecules
seems to be a common feature of T. cruzi
forms and has been described in epimasti-
gotes (3), tissue culture trypomastigotes (8,9)
and metacyclic trypomastigotes (10,11). If
the polymorphic expression of peptide epi-
topes in these studies has emerged as a fairly
common feature for T. cruzi (3,8,9), the
variability in the carbohydrate moieties
mainly attached to parasite surface glyco-
proteins is less well characterized (11). Other
parasitic protozoans like Plasmodium and
Leishmania have also been shown to display
extensive antigenic polymorphism (41,42).
There are numerous strains and clones of
T. cruzi being used by different laboratories.
These strains have distinct biological prop-
erties. Some isolates can even contain sub-
populations that range from highly lethal to
mildly infective in murine models (30). Al-
though the molecular basis for this diversity
is not known, it is likely that chromosomal
rearrangements also occur in T. cruzi, simi-
lar to what has been described for other
protozoans like Giardia, T. brucei and Plas-
modium (43).
Extracellular amastigotes of the Y strain
have been shown to be infective for different
cell types and are able to sustain an infective
cycle in vivo (14). Comparative studies car-
ried out with both intracellular and extracel-
lular forms of the Y strain indicate that extra-
cellular amastigotes are more infective and
comparatively more resistant to complement-
mediated lysis (Barros HC, Verbisck NV,
Da-Silva S and Mortara RA, unpublished
data). Although several studies have shown
that amastigotes can be found in the periph-
eral blood of infected animals (14,44), par-
ticularly during the acute phase of the dis-
ease, the role of circulating amastigotes in
the course of natural infection remains un-
clear (14,19). T. cruzi strains that are par-
ticularly virulent and lethal for animal mod-
els always induce high parasitemias, a fact
that has been correlated with the infectivity
of the circulating trypomastigotes. In pre-
liminary studies, we have found that extra-
cellular amastigotes from T. cruzi strains
that are less virulent and only cause subpatent
parasitemia, like the G and MD strains, are
far more infective to HeLa cells than forms
of the more virulent isolates like Tulahuen,
F, Y and CL strains (Barros HC, Da-Silva S
and Mortara RA, unpublished data). Whether
this unexpected pattern of infectivity is sig-
nificant in the natural course of infection in
vivo is not known, but this phenomenon
clearly deserves further investigation. Since
Ssp-4 is a major surface component of T.
cruzi amastigotes it could also play a role in
the process of parasite adhesion and inva-
sion.
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